Pfizer Inc. and two of its subsidiaries have agreed to pay $345 million under a proposed settlement to resolve lawsuits over EpiPen price hikes. In documents filed Thursday in federal court in Kansas ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results